• Bacteroides fragilis and Gut–Brain Antiseizure Signaling

  2026-09-22

  A 2026 Neuron study identifies a colonic ChAT+-vagal circuit through which Bacteroides fragilis suppresses seizures in mice and shows efficacy in children with refractory epilepsy. Its combination of microbiota manipulation, vagal recordings, causal neural perturbation, and clinical evaluation provides a mechanistic framework for microbiota-targeted antiseizure research.

• Bleomycin Sulfate: Reliable DNA Damage Models

  2026-09-21

  Learn how Bleomycin Sulfate, SKU A8331, supports controlled DNA-damage, cytotoxicity, and fibrosis workflows. This scenario-based guide connects mechanism, formulation, assay design, interpretation, and practical vendor-selection criteria for more defensible laboratory data.

• Reactive Astrocyte–Microglia Crosstalk in 1,2-DCE

  2026-09-21

  The reference study identifies reactive astrocytes as an early cellular driver of 2-chloroethanol-associated neuroinflammation, linking ROS-dependent p38 MAPK, NF-κB, and AP-1 signaling to A1 astrocyte activation and subsequent M1 microglial polarization. Its cell-based design provides a useful framework for separating direct chemical effects on microglia from cytokine-mediated astrocyte–microglia communication in toxic encephalopathy research.

• Azithromycin and Roxithromycin as Senolytics

  2026-09-20

  The reference study established a streamlined human fibroblast model for screening clinically approved drugs against senescent cells and identified azithromycin and roxithromycin as selective senolytic candidates. Its combination of viability, metabolic, autophagy, and real-time impedance measurements provides a useful framework for interpreting drug-induced senescent cell clearance while highlighting the need for orthogonal senescence validation.

• HyperScribe™ for Translational mRNA Design

  2026-09-19

  Explore how HyperScribe™ All in One mRNA Synthesis Kit II supports cap-, T7-, and poly(A)-focused mRNA workflows. This article translates findings from an LNP-mRNA fibroblast study into practical design, quality-control, and assay decisions for inflammatory disease research.

• Oteseconazole (VT-1161) Candida Workflows

  2026-09-18

  Build more reliable Candida susceptibility, resistance, and selectivity assays with Oteseconazole (VT-1161), a selective tetrazole CYP51 inhibitor. This practical workflow separates product-backed performance from assay starting points and shows how to troubleshoot solubility, controls, endpoint variation, and species-specific results.

• Light-Inducible RNA Release for Regulated Gene Therapy

  2026-09-18

  The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage. In mouse models, LIRP-regulated AAV systems enabled light-dependent treatment of diet-induced obesity and reversible control of VEGF inhibition in retinal disease, illustrating a potential safety advantage for on-demand gene therapy.

• Schisandrin B Mitigates Nickel Nanoparticle Lung Injury

  2026-09-17

  The reference study identifies a Sirt3-associated mitochondrial redox and lipid-metabolism axis in human lung epithelial injury caused by nickel nanoparticles. By combining computational toxicology with Sirt3 gain- and loss-of-function experiments, it shows that Schisandrin B is associated with improved mitochondrial function, lipid handling, inflammatory signaling, and apoptosis-related outcomes.

• QRICH1 Links ER Stress to HBV-Driven HMGB1 Secretion

  2026-09-17

  A 2025 Immunobiology study identifies QRICH1 as an important effector connecting endoplasmic reticulum stress with HMGB1 transcription, acetylation, translocation, and secretion during HBV-associated hepatic fibrosis. By combining a chronic rcccDNA mouse model, human liver specimens, histology, immunoassays, and molecular analyses, the work provides a mechanistic framework for interpreting inflammatory liver injury and for designing follow-up studies.

• Single-Molecule Imaging of R-Loop Collisions

  2026-09-16

  The reference study uses DNA-curtain single-molecule fluorescence imaging to show how individual R-loops interfere with Phi29 DNA polymerase progression. Its results identify strand orientation, exposed-DNA secondary structure, G-quadruplex formation, and transcription-complex occupancy as important determinants of replication stalling.

• Bismuth Subsalicylate: GI Assay Workflows

  2026-09-16

  Build more reproducible gastrointestinal disorder research workflows with Bismuth Subsalicylate while accounting for its water-, ethanol-, and DMSO-insoluble nature. This guide combines inflammation pathway modulation with annexin V membrane readouts to distinguish pathway effects from precipitation, cytotoxicity, and assay artifacts.

• CX-5461 RNA Polymerase I Inhibitor Workflows

  2026-09-15

  CX-5461 enables focused studies of Pol I-driven rRNA synthesis, nucleolar stress, DNA damage, autophagy, and senescence in cancer models. This practical guide connects formulation, dose-response design, cervical cancer findings, and cisplatin-combination assays to reproducible research workflows.

• Surfactant-Derived LNPs Deliver mRNA to Macrophages

  2026-09-15

  Huang and colleagues developed a dual-component lipid nanoparticle system that uses a surfactant-derived lipid and a fusogenic lipid to deliver mRNA into difficult-to-transfect macrophages. Their findings show that quaternary ammonium compound structure and formulation design can produce nuclease-resistant, biocompatible carriers without a PEGylated lipid, providing a useful framework for macrophage engineering.

• Temafloxacin Pharmacokinetics: 1991 Review

  2026-09-14

  Dudley’s review integrated human pharmacokinetic data for temafloxacin with pharmacodynamic considerations to explain its high oral bioavailability, prolonged elimination, tissue distribution, and dosing implications. The findings support once- or twice-daily administration while identifying renal function as the principal factor requiring interval adjustment.

• EGCG Nanoparticles Enhance FLASH-RT Antitumor Activity

  2026-09-14

  Xu and colleagues developed functionalized, self-assembled EGCG nanoparticles named BENPs to address the limited tumor control observed with FLASH-RT. In a breast tumor model, BENPs increased radiation-associated oxidative and DNA damage, promoted tumor-cell death, and reshaped systemic immune responses without an evident increase in measured toxicity.

8070 records 1/538 page Next 12345 下5页 Last page